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Peripheral T cells are divided into two subpopulations, CD4+ cells that respond
to antigen presented by class II MHC, and CD8+ cells that respond to antigen
presented by class I MHC (1) . Studies of the allograft response demonstrate that
both CD4 + and CD8+ subclasses ofT cells can interact in the mediation of rejec-
tion (2-10) . The relative roles of CD4+ and CD8+ cells in the rejection response
has been established by adoptive reconstitution ofT cell-depleted hosts with T cell
subsets (2-8) and by treating hosts with mAbs to deplete one or both subsets (9).
These studies show naive CD4+ cells have a predominant role in the majority of
strain combinations . Naive CD8+ cells alone can effect rejection in some strains (7,
8), but are usually dependent upon help from CD4+ cells (2-4) . If cells are previ-
ously sensitized, CD8 + cells alone can reconstitute rejection as they lose their de-
pendence for help from CD4+ cells (2, 6, 10) . Ts cells also become activated during
the allograft and otherimmune responses (11-1", , particularly in circumstanceswhere
graft rejection is prevented by immunosuppressive therapy (12, 13) or enhancement
(14, 15) . For both rejection (2, 3, 7) and suppressor responses (14, 16, 17), it has
been proposed that the class II MHC-reactive CD4 + cells primarily act to induce
the effector class I MHC-reactive CD8+ subclass . In vitro studies show cell surface
molecules, such as high and low molecular weight forms ofT200, can be used to
identify these effector and suppressor subpopulations of CD4 + and CD8+ T cells
(16, 17) .
We have examined the cellular basis of both allograft rejection (3, 10, 18) and the
maintenance of specific unresponsiveness induced by cyclosporine (CSA)t treatment
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(12, 13) in DA rats grafted with hearts from class I and II MHC-incompatible PVG
donors. In this strain combination the restoration of graft rejection in sublethally
irradiated hosts is dependent upon CD4+ cells (3, 10, 18). Although naive CD8+
cells alone do not effect rejection, synergy with CD4+ cells has been demonstrated
in that graft rejection time in hosts reconstituted with both CD4+ and CD8+ cells
is faster than in those given CD4+ cells alone (3). Specific sensitization does not alter
the capacity of CD4+ cells to restore rejection (10, 13), but sensitized CD8+ cells
show specific sensitization in that pure populations of these cells can restore graft
rejection (10, 13). These results confirm the role of naive and sensitized CD8+ cells
as effectors of rejection that was proposed by in vitro studies of the alloimmune re-
sponse (19, 20).
CSA or enhancing antibody treatment prevents rejection of organ allografts in
rats and allows the development of specific unresponsiveness to donor strain grafts
-50 d after transplantation (12-15, 21-23). After this time CD4+ cells from DA hosts
are unable to restore original donor graft rejection, and can also inhibit the restora-
tion of rejection by naive lymph node or CD4+ cells (12, 13, 15). Before 50 d, CD4+
cells retain the capacity to effect graft rejection, and CD8+ alone gain the capacity
to restore rejection in the irradiated host (13, 15), suggesting that they are sensitized
to donor antigens.
In this study the nature of CD4+ suppressor cells in DA rats with long-surviving
PVG heart grafts was further characterized. Their capacity to block restoration of
rejection by naive and sensitized CD4+ and CD8+ cells was examined to test
whether this suppressor cell could mediate the downregulation of the CD4+ cells
and sensitized CD8+ cells that are present in the host in the first few weeks before
unresponsiveness develops. The requirement of CD8+ cells for the mediation of sup-
pression was also examined, in particular whether radioresistant or regenerating
CD8+ cells in the adoptive host were necessary for the reinduction of unresponsive-
ness. We also examined whether the CD4+ suppressor cells could be subdivided
from the CD4+ cells that induce the rejection response by phenotype, by life span,
and by sensitivity to cyclophosphamide (14, 16).
Materials and Methods
Rats.
￿
Rats of the DA (RTIa), PVG (RTIc), and Wistar Furth (W/F; RTlu) strain were
bred and maintained in the Medical School Animal House, at the University of Sydney. In
the U. S., DA and PVG were purchased from Bantin and Kingman (Fremont, CA) and W/F
were from Harlan Sprague Dawley, Inc., (Indianapolis, IN).
OperativeProcedures.
￿
DA rats, anesthetized with ether, were grafted with PVG or W/F hearts
by end-to-side anastomosis of the ascending aorta to abdominal aorta and the pulmonary
artery to the inferior vena cava, as described elsewhere (24). Donors were 150-200-g female
rats, and recipients were 250-300-g male rats. Graft ischemia times ranged from 25 to 40
min, and all grafts commenced to contract within 2 min of reanastomosis. Graft function
was monitored daily by palpation ofcontraction and electrocardiogram. On the day function
was lost, grafttissue was obtained for histological confirmation ofrejection. Experiments were
terminated if grafts survived >100 d. Long surviving grafted hearts were removed by liga-
tion of the aorta and pulmonary artery.
Thymectomy was performed, as described (25), on 4-6-wk-oldDA rats, and animals were
used 6 wk later.
Treatment ofRats to Induce Long-term Graft Survival.
￿
DA rats were grafted with PVG hearts
and given CSA (Sandoz, Basle, Switzerland) at a dose of 20 mg/kg/d, for 10 d, as described
(12). Grafts in treated animals survived for >100 d, compared with a survival time of 6-8 dHALL ET AL.
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in untreated control animals. Unless otherwise stated, CSA-treated cell donors were animals
who had PVG heart grafts functioning X75 d.
CellPreparations.
￿
Single cell preparations from spleen and lymph node cells (LNC) were
prepared in Dulbeccds PBS with calcium and magnesium (DAB; Oxoid, Oxford, UK) con-
taining 10% FCS (Flow Laboratories, North Ryde, Australia), as described elsewhere (26).
Subpopulations oflymphocytes were identified using an indirect immunofluorescence tech-
nique (12, 17), with the mouse mAbs MRC Ox19 (pan T, CD5) (27), W3/25 (CD4) (28),
MRC Ox8 (CD8) (28), MRC Ox17 (Ia) (29), MRC Ox22 (CD45R) (30), and MRC Ox39
(IL-2-R) (31) (Sera Laboratories, Oxford, UK) as the first stage, and FITC-labeled rabbit
anti-mouse Ig (Dako Corp., Copenhagen, Denmark) as the second stage. Ig' cells were
identified using FITC-labeled rabbit anti-rat Ig (Dako Corp.) (26). Stained cells were enumer-
ated on a FAGS 440 or a FAGS Star (Becton Dickinson & Co., Mountain View, CA).
CellSeparation.
￿
Full details ofcell separation techniques have been described (18). Briefly,
CD4' and CD8* T cell subsets were separated by binding MRC Ox8 or W3/25 at saturating
concentrations to cells before panning on plastic petri dishes (Lab Tek; Miles Laboratories
Inc., Naperville, IL) coated with both sheep anti-mouse Ig (Silneus Laboratories, Pty. Ltd.,
Hawthorn, Australia) and sheep anti-rat Ig (Silneus Laboratories, Pty. Ltd.). The nonad-
herent populations from MRC Ox8-bound cell populations was 90-95% W3/25', 1-217o Ig',
and 1-4% MRC Ox8' ; that from W3/25bound cell populations was 85-90% MRC Ox8',
1-4o7o Ig', and 2-8olo W3/25'. To separate subpopulations of CD4' cells, MRC Ox8 was
combined with MRC Ox22, MRC Ox17, or MRC Ox39. Cellswere immediately transferred,
except in experiments examining survival in vitro, where they were cultured in RPMI (Flow
Laboratories), 10% FCS, 5 x 10-5 M 2-ME, 2 nunol t,-glutamine, penicillin (100 U/ml), and
streptomycin (100 Ug/ml), in a 5% COz incubator at 37'C.
Treatment with cyclophosphamide (20 mg/kg i.v) (Bristol Laboratories, NSW, Australia)
was given to cell donors 48 h before cell donation to study cell life span in vivo.
MCR 0x8 TreatmentofAdoptive Host.
￿
MRC Ox8 was produced from the clone, generously
provided by Dr. A. Williams, MRC Cellular Immunology Unit, Oxford, UK, in ascites in
BALB/c mice (obtained from Radiation Biology, Stanford, CA) primed with IFA (Difco
Laboratories, Inc., Detroit, MI). Ascites with 7 mg of MRC Ox8 was given intraperitoneally
to the host two d before, then 1 and 4 d after grafting.
Adoptive Transferences.
￿
Donor and recipient rats for adoptive transfer experiments were
given whole body irradiation; in Sydney at 1 Gy/min to a total dose of 9 Gy from a 60 Co
source, as described before (26), and at Stanford at 1 Gy/min to a totaldose of6.25 Gy from
a Philips X-ray machine (250 kV, 15 mA) (Philips Electronic Instruments, Inc., Mahwah,
NJ). The dose ofirradiation was determined as that required to prolong PVG and W/F skin
graft survival from 8-10 d to > 15 d, but with a mortality of<20% from irradiation. Within
24 h the DA recipients were grafted with hearts from PVG or W/F donors. Irradiated DA
recipients given no cellsdo not reject PVG or W/F hearts for at least 34 d, and many retain
their grafts indefinitely (>150 d). The capacity to reject a heart from either strain can be re-
stored to irradiated recipients by the adoptive transfer of normal syngeneic LNC or spleen
cells, T cells, or W3/25' T cells (3, 18, 26). All subpopulations of cells from CSA-treated
rats with long-surviving PVG allografts (>75 d) are unable to restore PVG, but do restore
W/F heart graft rejection (12). W3/25', but not MRC Ox8' cells, are able to suppress the
restoration of PVG heart graft rejection by naive LNC or W3/25' cells, when mixed in a
ratio of 3-4:1 (12).
Statistics.
￿
Differences in rejection time between groups of rats restored with equivalent
inocula were analyzed usingthe Wilcoxon rank sum test. A p value of<0.05 was considered
significant.
Results
We have recently reported that during the induction phase, grafted rats destined
to become unresponsive contain both W3/25+ and MRC Ox8+ cells with the ca-
pacity to restore donor strain rejection in irradiated adoptive hosts(13, 15) (see Table
I). At 8 and 20 d post-grafting, the W3/25' T cell subset (data for day 8 shown144 CHARACTERIZATION OF THE CD4+ SUPPRESSOR CELL
TABLE I
Comparison of Capacity of W3125+ and MRC Ox8+ Cells from DA Rats Grafted
with PVG Hearts, Either Treated or not Treated with CSA, to Adoptively Restore
Rejection of PVG and WIF Heart Grafts in Irradiated DA Hosts
' Significantly different (p < 0.001) from the restorative capacity of all other W3/25' populations tested.
These groups had survival times intermediate between that of naive and sensitized rats, but did not reach
significant differences with either.
s Significantly different from naive and d75 CSA-treated cells (p < 0.001) .
in Table I, line 2) cells retained the capacity to adoptively restore graft rejection
of both PVG and W/F grafts, in a tempo comparable with that of naive cells. By
day 50 and subsequently, the W3/25' cells were unable to restore PVG rejection
but could effect third party W/F rejection (data for day 75 shown in Table I, line
3). This change required both the maintenance of the graft and CSA treatment,
as W3/25' cells from rats grafted with PVG hearts but not treated with CSA did
effect rejection ofboth PVG andW/F hearts in irradiated hosts (see Table I, line 4).
MRC 0x8+ cells from CSA-treated heart-grafted rats taken on days 8, 20, and
50 post-transplantation could restore PVG rejection in some adoptivehosts, but by
75 d and subsequently had lost their capacity to restore rejection (13) (data for day
8 and day >75 shown, Table I, lines 6 and 8). As naive MRC Ox8' cells were un-
able to reconstitute PVG rejection (Table I, line 5) these findings showed that in
the first 50 d there was activation akin to what occurs in unmodified rejection, in
that MRC Ox8' cells could effect rejection independent ofW3/25' cells (see Table
I, line 7) (13). The sensitized state ofMRC Ox8' cells was not sustained, however.
In sensitized hosts, 75-d post-transplant MRC Ox8 cells showed specific sensitiza-
tion, in that they effected PVG but not W/F rejection (Table I, line 9) while day
75 MRC Ox8+ cells from CSA-treated rats with PVG grafts effected neither PVG
nor W/Frejection (Table I, line 8). Thus, CSAtreatment did not prevent a transient
sensitization ofMRC Ox8+ cells, nor did it immediately reduce the alloreactivity
of W3/25' cells. The W3/25' cells lost alloreactivity and the MRC Ox8' cells lost
their sensitized state, -50 d post-transplantation, which is about the time when un-
responsiveness to second donor grafts is acquired by the CSA-treated host (22, 23).
We have previously shown that W3/25' (see Table II, line 1) and not MRC Ox8'
Cell donor 5 x 106 Cells Median
PVC grafts
Range
Graft
No.
survival
Median
W/F grafts
Range No.
d
Naive W3/25' 13 11-33 14 22 .5 22-30 4
CSA-treated (day 8) W3/25' 11 8-11 4 28 19-33 3
GSA-treated (day 7) W3/25+ >100 >100 5' 21 21-26 5
No CSA (day 75) W3/25+ 19 11-24 6 35 19-43 8
Naive MRC Ox8' >100 >100 6 43 16-55 5
GSA-treated (day 8) MRC Ox8` 52 6->100 131 28 16-47 8
No CSA (day 8) MRC Ox8' 46 8->100 121 31 11->100 12
CSA-treated (day 75) MRC Ox8' >100 >100 4 47 14->100 3
No GSA (day 75) MRC Ox8' 21 11-22 5§ >100 35->100 9
>100 40->100 8 >100 34->100 10HALL ET AL.
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TABLE II
Capacity of W3/25' Suppressor Cells to Inhibit Restoration of PVG Heart Graft Rejection by
Naive or Sensitized W3/25' Cells in Irradiated DA Rats
' 2 x 107 W3/25' suppressor cells from CSA-treated DA rats with PVG heart grafts.
cells from DA rats with PVG hearts surviving >75 d could suppress the reconstitu-
tion of rejection in irradiated hosts of PVG, but not third party hearts by naive
W3/25' cells (12). As both the CD4 and CD8 cells in CSA-treated hosts appear to
be sensitized to PVG shortly after transplantation, we examined whether the
W3/25' suppressor cells in rats with long surviving grafts could account for the
downregulation of these sensitized cells' capacity to effect rejection.
Examination of the Capacity of W3/25' Cellsfrom Unresponsive Rats to Suppress Spe-
cifically Sensitized W3/25' cells. The effect of W3/25' cells from CSA-treated rats
on the various population ofW3/25' cells is shown in theleft hand column of Table
II and the capacity to effect rejection of the W3/25' cells alone is shown in the right
hand column of Table II. W3/25' cells from CSA-treated rats suppressed 5 x 106
naive W3/25' cells (Table II, line 1) but did not suppress sensitized W3/25' cells
taken either 8 (line 2) or 75 d (line 3) after grafting. Specifically, sensitized W3/25'
(5 x 106) cells obtained from DA rats 8 and 75 d after grafting a PVG heart re-
stored rejection in a tempo similar to that of equivalent numbers of naive W3/25'
cells (see Table II, right hand column). This is the first difference we were able to
demonstrate between naive and sensitized W3/25' cells in the alloimmune response
of DA rats. This effect of sensitization was shown to be specific; in that W3/25' cells
from CSA-treated rats did suppress W3/25' from animals that had rejected a third-
party heart (Table II, line 4).
Even though suppressor W3/25' cells from CSA-treated rats did not suppress day
8 specifically sensitized W3/25' cells, they did suppress the restoration of PVG re-
jection by W3/25' cells from day 8 CSA-treated DA rats grafted with PVG hearts
(Table II, line 5). These results suggest that CSA may prevent or limit the sensitiza-
tion of W3/25' cells during the induction phase. It was concluded that the W3/25'
suppressor cell from specifically unresponsive rats impaired the capacity of the
W3/25' cells present in the CSA-treated host for several weeks after transplanta-
tion to effect rejection, even though it wasunable to suppress rejection by sensitized
W3/25' cells.
Examination ofthe Capacity of W3/25' Cellsfrom Unresponsive Rats to Suppress MRC
0x8' Cells. Naive MRC Ox8' cells alone did not adoptively restore rejection in
irradiated hosts (3); therefore, the effects with W3/25' suppressors on these cells
could not be examined without the addition of naive W3/25' cells (Table III, line
Source of 5 x 106 Rejection time
W3/25' cells Hearts surviving with Hearts surviving
DA sensitized: suppressor cells' without suppressor cells
To strain On day Median Until day (n) p Median Until day (n)
- 0 >100 14, 15, 17, >100(7) <0.01 13 11(2), 12(5), 14, 18(5), 33
PVG 8 22 15, 18, 25, 53 NS 10 10(3), 22(2)
PVG 75 15 15(4) NS 24 11, 13, 24(3)
W/F 8 >100 30, >100(4) <0.05 14 11, 14(2)
PVG/Rx CSA 8 >30 15, >100(4) <0.05 11 8, 11(3)146
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TABLE III
Capacity of W3/25+ Suppressor Cells to Inhibit Restoration of PVG Heart Graft Rejection by
Normal or Sensitized MRC 0x8+ Cells in Irradiated DA Rats
' 2 x 107 W3/25+ Suppressor cells from CSA-treated DA rats with PVG heart grafts.
1). In rats restored with both 2 x 107 MRC Ox8+ and 5 x 106 naive W3/25+ cells
(Table III, line 2), rejection occurred faster than in rats restored with naive 5 x
106 W3/25+ cells alone (Table II, line 1). 2 x 107 W3/25+ cells from CSA-treated
rats significantly delayed rejection in rats restored with both the 5 x 106 naive
W3/25+ and naive 2 x 107 MRC Ox8+ cells and induced indefinite survival in two
of eight rats (Table III, line 2). This inhibitory effect of W3/25+ suppressors was
not as great as that against 5 x 106 naive W3/25+ cells alone, where 7 of 10 rats
went on to indefinite graft survival (Table II, line 1).
Sensitized MRC Ox8+ cells were also suppressed by W3/25+ cells from CSA-
treated hosts. MRC Ox8+ cells taken 8 or 75 d post-grafting from normal rats that
had rejected a PVG graft were able to restore rejection without help from naive
W3/25+ cells (Table III, lines 3 and 4). MRC Ox8+ cells taken at day 8 did not in-
variably restore rejection, but those taken atday 75 did. There appeared to be sup-
pression by the W3/25+ CSAcells ofboth day 8 and 75 sensitized MRC Ox8+ cells,
although due to the variable capacity ofday 8 MRC Ox8+ cells alone to restore re-
jection, the effect of the W3/25+ suppressor cell did not reach significance. These
findings showed that the W3/25+ suppressor cell could directly inhibit the genera-
tion and/or action ofsensitized MRC Ox8+ cells as effectors ofrejection. Thus, the
W3/25+ suppressor could account for the inhibition ofthe sensitized MRC Ox8+
cellsthatoccurs inCSAtreatedhosts during thefirst 2mopost-transplant. Thegreater
proportion of rejected grafts in the group given naive MRC Ox8+ cells suggests that
rather than acting as effectors ofsuppression, the cells were activated as effectors
ofrejection. Theseexperiments did not examinethe roleadoptive host-derived MRC
Ox8+ cells might play as effectors of suppression, however.
Examination ofthe Role ofAdoptive Host-derivedMRC 0x8+ Cells in the Mediation of
Suppression by W3/25+ Cells. The role that host-derived MRC Ox8+ cells may play
as effectors ofsuppression that are activated by the transferred W3/25+ suppressor
cells were examined using adult thymectomized (AT.) irradiated hosts in which
regeneration ofMRC Ox8+ T cells is limited (Table IV), orby treating the adop-
tive hosts with MRC Ox8 mAb to deplete these hosts ofradioresistant MRC Ox8+
cells (Table V).
Restorative inocula With suppressor cells'
Rejection time
Without suppressor cells
MRC
No.
OW
Sensitized to
No. naive
W3/25+ Median
Hearts surviving
until day (n) p Median
Hearts surviving
until day (n)
2 x 107 No - - ND - >100 73, >100(4)
2 x 107 No 5 x 106 24.5 16(4), 35(2), <0.01 7 7(3), 9(2)
>100(2)
5 x 106 PVG d8 - >100 18, >100(3) NS 40 8, 12, 17(3), 40, 51,
54, 66(2), >100(2)
5 x 106 PVG d>75 - >100 26, >100(4) <0.05 21 21(4), 22HALL ET AL.
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TABLE IV
Capacity of W3/25+ Suppressor Cells to Inhibit Restoration of PVG Hearts by
Naive W3/25+ Cells in Irradiated DA Rats Further Depleted of
MRC OW Cells by Thymectomy
' W3/255' suppressor cells from CSA-treated rats with PVG heart grafts.
AT, recipient DA rats were thymectomized 6 wk before grafting.
In a previous study, it was shown that whole body irradiation depletes MRC
Ox8+ and W3/25' Tcell populations to <5% ofnormal peripheral lymphoid tissue
content (25). Regeneration starts within 2 wk and CD8+ cells recover more rapidly
than CD4+ cells. Both subgroups are repleted to near normal by 7 wk. In AT. ir-
radiated hosts, recovery ofCD8+ T cells is nearly abolished and there is only a 10%
recovery of CD4+ T cells (25).
Thus, we examined whether cells produced by the regenerating thymus of the
irradiated adoptive hosts would be required to contribute to reestablishment ofun-
responsiveness. This was not the case, as W3/25+ cells from unresponsive hosts sup-
pressed the restoration ofgraft rejection by naive W3/25+ cells in irradiated ATX
hosts in all five rats tested (Table IV, line 2), compared with 7 of10 innon-AT. hosts.
AT. did not prevent naive W3/25' cell restoring rejection, as irradiated AT. con-
TABLE V
Examination of the Effect of Depletion ofMRC Ox8' Cellsfrom Irradiated DA Hosts by
Treatment with mAb MRC 0x8 on the Transfer by W3/25+ Suppressor Cells of
Unresponsiveness Toward PVG Heart Grafts
' W3/25' suppressor cells from CSA-treated DA rats with PVG heartgrafts.
Restorative
No. suppressor
W3/25"
inocula
No. naive
W3/25'
Irradiated
host
treatment Median
Rejection time
Hearts surviving until day
(n) P
2 x 10' 5 x 106 - >100 14, 15, 17, >100(7) -
2 x 10' 5 x 106 AV >100 >100(5) NS
- 5 x 106 AV 27 17, 20, 27, 31, >100 <0.001
- 5 x 106 - 13 11(2), 12(5), 14, 18(5), 33 NS
- - - >100 40, 53, 68, >100(5) <0.001
Rejection time
Irradiated and MRC
Restorative inocula: Irradiated hosts Ox8-treated hosts
no. W3/25'
Suppressor*
cells
Naive Median
Heart surviving
until day (n) Median
Heart surviving
until day (n) Significance
(P)
- - >100 >100(4) 16.5 13, 16, 17, 39 0.05
NS
2 x 101 - >100 >100(5) 38 36(2), 38, 40, >40 0.05
0.01
2 x 107 5 x 106 >100 >100(4) 11 7(2), 11, 13, 15 0.05
NS
- 5 x 106 13 13(4) 14 10, 11, 14(2), 20 NS148
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trols restored with naive W3/25+ cells alone rejected their grafts (Table IV, com-
pare lines 3 and 4), albeit with a trend to a slower tempo in AT. hosts. This latter
result confirms that the effect of W3/25+ suppressors was inhibitory and that the
AT. host when reconstituted with W3/25+ cells did not lack cells necessary to re-
ject the graft. Takentogether, theseresultsstrongly suggest that thymus-derived cells
are not required to be effectors of the suppressor response transferred by the
W3/25+ cells.
As irradiation does not totally ablate MRC Ox8+ cells in peripheral lymphoid
tissues (25), we examined the role these cells may play in transfer of suppression,
by treating the adoptive host with the mAb MRC Ox8. This antibody is effective
at nearly totally depleting MRC Ox8+ cells in normal hosts (32); and in irradiated
hosts, no MRC Ox8+ cells can be found in lymph node or spleen 2 wk after treat-
ment with both irradiation and MRC Ox8 therapy (Gurley, K. E. and B. M. Hall,
unpublished results). Surprisingly, controls treatedwith MRC Ox8 andirradiation,
but not restored with any cells, all rejected their grafts, while irradiated rats given
neither MRC Ox8 nor cells did not reject their grafts (Table V, line 1). This sug-
gested that MRC Ox8+ cells in irradiated hosts suppressed recovery of the alloim-
mune system and prevented rejection of the graft. Irradiated MRC Ox8-treated
hosts given W3/25+ suppressor cells from CSA-treated rats also rejected their grafts,
while non-MRC 0x8-treated hosts never rejected (Table V, line 2). Although this
tended to be slower than nonreconstituted irradiated, MRC Ox8-treated controls,
the difference did not reach significance. Further, W3/25+ suppressor cells, mixed
with naive W3/25+ cells, failed to inhibit the latter cells in irradiated MRC
Ox8-treated hosts (Table V, line 3); whereas in non-MRC Ox8-treated irradiated
hosts, the same naive cells are suppressed. MRC Ox8 treatment of irradiated hosts
restored with naive W3/25+ cells did not impair these cells' capacity to affect rejec-
tion, in that the rejection tempo was similar to that in irradiated hosts restored with
only naive W3/25+ cells (Table V, line 4).
Taken together, these results show the rejection response in irradiated rats is in-
hibited by an MRC Ox8+ cell that was radioresistant but not thymus derived. This
cell was critical for the transfer of suppression by the W3/25+ cells from CSA-treated
hosts.
Role of Thymus and MRC 0x8 Therapy in Generation of W3/25' Suppressor Cells in CSA-
treated Rats. The independence of the generation and maintenance of suppression
from the thymocytes or cells recently derived from thethymus was furtherconfirmed
by experiments in which unresponsiveness was induced by CSA in AT,, hosts.
Indefinite graft survival was induced in all AT,, hosts treated with CSA (n = 10),
and in control AT,, rats not treated with CSA, all grafts were rejected in first set
(7 d [n = 6]). 2 x 107 W3/25+ cells taken from these AT,, CSA-treated rats with
long surviving grafts (>75d) suppressed the capacity of 5 x 106 naive W3/25+ cells
to effect rejectionin the adoptive transfer assay, allfour grafts surviving>100 d(Table
VI, line 2). W3/25+ cells from AT. donors that had not been grafted or treated with
CSA restored graft rejection in a normal tempo (Table VI, line 3), which indicated
that thymectomy itself did not result in CD4 + cells becoming suppressor cells or
in the depletion of these cells. It was concluded that cells recently derived from the
thymus did not contribute to the generation of suppressor cells. This complements
the findingthat reestablishment of unresponsiveness in the irradiated adoptive hostHALL ET AL.
TABLE VI
Capacity of W3125' Cells from Thymectomized CSA-treated DA Rats with
PVG Hearts to Restore PVC Heart Graft Rejection in Irradiated DA Rats
" Adult rats were thymectomized 6 wk before grafting.
was also thymus independent. Treatment of normal hosts with CSA and MRC Ox8
for 2 wk also did not impair induction of unresponsiveness. MRC Ox8 therapy to
normal DA hosts had only minoreffects in delaying PVG rejectionfrom 6-8 to 8-10 d,
even though this therapy depleted peripheral CD8+ cells to <27o of peripheral blood
lymphocytes compared with 15-187o in normals.
Phenotype of the W3/25+ Suppressor Cell.
￿
Using the panning technique, W3/25'
suppressor cells were further depleted of cells identified by the mAbs MRC Ox17,
MRC Ox22, and MRC Ox39. MRC Ox17, which identifies la antigens of the rat,
was found on 12To of W3/25' cells from both naive andCSA-treated rats with long
surviving grafts. Depletion of these cells did not totally eliminate suppression, al-
though W3/25' MRC Oxl7- cells did not appear as effective as the unfractionated
W3/25' cells (Table VII, line 1). In all rats there was a rejection episode in the
14-30-d post-transplant period, from which four of eight grafts recovered function.
Twoofthe rats that recovered subsequently rejected their grafts at 53 d. These rejec-
tion crises were never observed in rats restored with unfractionated W3/25' cells
from unresponsive hosts. MRC Ox22 binds to 50-6017o of W3/25' cells in CSA-
treated and naive rats, and removal ofthis subset depleted suppressor function (Table
VII, line 2) .
Removal of the IL-2-R-bearing cells by MRC 009 therapy also abolished the
TABLE VII
Examination of the Phenotype of W3125+ Suppressor Cells to Inhibit Adoptive Restoration of
PVG Heart Graft Rejection by Naive W3125' Cells
" W3/25' suppressor cells from C8A-treated DA rats with PVG heart grafts.
1 Significance compared with rats restored with 5 x 106 naive W3/25' cells alone.
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Restorative
No. suppressor
W3/25
inocula
No. naive
W3/25
Donor/s
ATx" Median
Rejection time
Cell hearts surviving
until day (n) P
2 x 10' 5 x 106 - >100 14, 15, 17, >100(7)
2 x 10' 5 x 106 + >100 >100(4)
NS
5 x 106 + 24 9, 16, 24, 26(2)
<0.01
NS
5 x 106 - 13 11(2), 12(5), 14, 18(5), 33
Restorative inocula
2 x 10' W3/25'
suppressor cells'
depleted with the mAb
No. naive
W3/25 Median
Rejection time
Hearts surviving until day (n) Significancel
MRC Oxl7 (1a) 5 x 106 43 16, 20, 33(2), 53(2), >100(2) P < 0.001
MRC Ox22 (CD45R) 5 x 106 21 14, 18, 21, >100 NS
MRC 009 (IL-2-R) 5 x 106 15 14(2), 15, 39, >100 NS
Nil 5 x 106 >100 14, 15, 17, >100(7) P < 0.01
- 5 x 106 13 11(2), 12(5), 14, 18(5), 33 -150
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suppressive capacities of the W3/25+ cells (Table VII, line 3). In CSA-treated
animals and normal DA rats, IL-2-R' cells accounted for 9 and 5%, respectively,
of the W3/25+ population.
Life Span of W3/25+ Suppressor Cells.
￿
The life span ofthe W3/25+ suppressor cell
was assessed in severalways. Its dependence on antigen in the functioning graft was
tested by removal ofthe heart and transferring the W3/25+ cells 1 and 3 wk after
the heart graft was removed. By 8 d after removal ofthe heart graft, W3/25+ cells
from CSA-treated rats (Table VIII, compare lines 1 and 2), which were 50 d post-
grafting, restored rejection in three offour rats. In contrast, W3/25+ cells from con-
trols that had not had their grafts removed were unable to effect rejection in three
of four adoptive hosts. W3/25+ taken 11-21 d after removal of the heart in CSA-
treated rats that had maintained a PVG graft for >100 d did not effect rejection in
four of six rats (Table VIII, compare lines 3 and 4).
Cyclophosphamide given to unresponsive CSA-treated hosts, 48 h before adop-
tive transfer ofW3/25+ cells, abolished their capacity to suppress in all four rats
tested (Table VIII, line 6), compared with thosefromnoncyclophosphamide-treated
hosts, whichsuppressed in7 of10(Table VIII, line 7). Cells from cyclophosphamide-
treated unresponsive animals on their own were unable to restore rejection (Table
VIII, line 5). The latter was not an effect ofcyclophophamide, as W3/25+ cells from
naive rats given cyclosphosphamide retained normal capacity toeffect rejection (data
not shown). Thisresult suggestedcyclophosphamide partiallydepletes suppressorcells.
Cells from CSA-treated rats cultured in vivo for 3 d (Table VIII, line 9), but not
1 d (Table VIII, line 8), regained thecapacity to restore rejection and, by inference,
lost the capacity to suppress.
These experiments showed that the W3/25+ suppressor cell had a short lifespan
and was probably dependent on cell division and exposure to graft antigens. After
cyclophosphamide treatment the W3/25+ cells' capacity to suppress naive cells pre-
cededtherecoveryoftheircapacity to effect rejection. However, in vitro the popula-
tion of cells that survived 3 d in culture did have the capacity to effect rejection.
This suggested that there were two populations within the W3/25+ cells of CSA-
treated hosts unresponsive to allografts, a short-lived suppressor and alonger lived
cell withthe potential toeffect rejection. Ifthis is thecase, the short-lived suppressor
cells prevented the mediation of graft destruction by the longer lived W3/25+ cells
with the potential to effect rejection.
Discussion
Ourstudiesdemonstrated that transfer ofspecific suppressionwasdependentupon
the CD4+ (W3/25+) cells alone and that this cell had the capacity to induce the un-
responsive state intheCSA-treated host, inthat it wascapableofinducingthedown-
regulation ofthe normal alloreactive CD4+ T cells and specifically activated CD8+
cellsthat were present inthehostin thefirst weeks aftertransplantation. The reestab-
lishment of unresponsiveness in adoptive hosts by CD4+ suppressor cells was de-
pendent upon a radioresistant MRC Ox8+ cell, which was not depleted by irradia-
tion and thymectomy. Depletion of this MRC Ox8+ cell required MRC Ox8
antibody therapy in addition to irradiation. The nature of this MRC Ox8+ cell,
whetheritbe aTcell oranatural suppressor cell, is yetto be defined, as is its mecha-TABLE VIII
Experiments to Examine the Life Span of W3/25+ Suppressor Cells Using the
Irradiated Adoptive Host to Examine for W3/25+ Cell Function
Restorative inocula
HALL ET AL.
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" W3/25+ suppressor cells from CSA-treated DA rats with long-surviving PVG allografts.
1 Numbers in parentheses are numbers of hearts surviving to that day.
nism ofcollaboration with specific CD4+ suppressor cells to promote reestablish-
ment of the unresponsive state in the irradiated host. The role of these cells in the
maintenance ofunresponsivenesswas unclear, as extensive studies inthismodel have
failed to show that CD8+ cells alone can transfer unresponsiveness (22); ifthey are
suppressor, their function may be dependentupon the CD4' suppressor. Their role
in the induction ofunresponsiveness by CSA is also unclear, as MRC Ox8 therapy
combined withCSAdid notprevent induction ofunresponsiveness. We alsodemon-
strated that CD4' suppressor cells expressed CD45R, IL-2-R, and probably class
Il MHC. CD4' suppressors were not dependent upon cells recently derived from
the thymus, but were relatively short lived and dependent upon the graft, presum-
ably as a source of alloantigen to prime the response. This CD4' suppressor cell
had many characteristics of the suppressor/inducer cell described in other models
(11, 14, 16, 33, 34).
Suppressionprimarily mediated byCD4' cells occurs in neonatally induced toler-
ance to alloantigen (35), in a tumor allograft model (36, 37), and in active and pas-
sive enhancement models (15, 33). The development of a CD4+ suppressor after
the activation ofCD8' cytotoxic effector cells is also similar to the findings ofNorth
and Bursuker (36, 37), whoshow that after transplantation oftumorgrafts intosemi-
syngeneic hosts, Ly-1-, -2' sensitized effector cells are generated but fail to destroy
the tumorbecause they are downregulated by Ly-1', -2-, Ts cells. Similarly, in CSA-
treated hosts andother models that go on to developspecific unresponsiveness, specific
W3/25' cells from
Treatment of cell
donor or cells
CSA-treated
d Post-
transplant
rats'
No.
5 x 106
W3/25' from
naive DA Median
Rejection time
Hearts surviving
until day P
- -50 5 x 106 - >100 36, >100 (3)1
NS
Graft removed
8 d earlier -50 5 x 106 - 20 11, 15, 25, >100
- -100 5 x 106 >100 >100 (6)
Graft removed
NS
11-21 d earlier -100 5 x 106 - >100 17, 20, >100 (4)
Cyclophosphamide
2 d earlier >75 2 x 107 >100 41, 75, 78, >100 (4)
Cyclophosphamide
<0.001
2 d earlier >75 2 x 107 + 25 16, 22, 26 (2)
- >75 2 x 107 + >100 14, 15, 17, >100 (7)
NS
Cultured in vitro
1 d >75 5 x 106 - >100 >100 (8) <0.001 Cultured in vitro
3 d >75 5 x 106 - 19 6, 18, 20, 21
- >75 5 x 106 - >100 >100 (6) <0.01152
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cytolytic T cells can be isolated from thehost shortly after transplantation (38, 39),
but do not effect irreversible graft destruction, perhaps due to their inhibition by
the suppressor cells. Our studies have shown that CD8+ cells in CSA-treated hosts
become sensitized to graft antigens, but this sensitization is lost after 50 d, a time
when specific unresponsiveness is manifest (13). In this study we directly demon-
strated that the CD4+ suppressor cell could inhibit the capacity ofsensitized CD8+
cells to effect graft rejection; thus demonstrating that the suppressor cell had the
capacity to switch offthis arm ofthe rejection response. With CD4+ cells, the sup-
pressors inhibited naive CD4+ cells as well as CD4+ cells from CSA-treated hosts
at a time shortly aftertransplant when theyhad the capacity to effect rejection. The
CD4+ suppressor's inability to inhibit sensitized CD4+ cells was the first difference
between sensitized and naive CD4+ cells that we have demonstrated. A similar
failure toinhibit sensitized cells butnotnaive cells hasbeen observed in experiments
using unfractionated cells from rats with specific unresponsiveness induced by an-
tithymocyte globulin (40). Further, cells from rats with specific unresponsiveness
to their allograft induced by either CSA or enhancement protocols only delay the
restoration of rejection by sensitized CD4+ cells in AT,-irradiated and bone mar-
row-reconstituted rats, and do not reinduce unresponsiveness (4, 33, 41, 42). The
failureofTscells toinhibitsensitized cells mayalsoexplain the difficultyin inducing
unresponsiveness in specifically sensitized hosts (43, 44).
The finding that the CD4+ suppressor is MRC Ox22+ (CD45R) is consistent
with previousreports that the suppressor/inducer cells in rats (30, 35) and man (45)
express CD45R, the high molecular weight form of T200. This marker does not
differentiate the suppressor cell from the effectors of rejection, in that the CD4+
MRC Ox22+ population in rats contains the T cells that produce IL-2 (46), which
proliferate to alloantigen in vitro and in graft vs. host disease (30), and which in
naive hosts reconstitute rejection to irradiatedhosts (Gurley, K. E. and B. M. Hall,
unpublisheddata). As memorycellsthatprovidehelpforantibodyresponses tosoluble
antigen are MRC Ox22- (30, 46), it is unlikely that the MRC Ox22+ suppressor
cell mediates its effect by induction ofan alloantibody response, akin to enhance-
ment. Thismechanismis also unlikely because ofourprevious findingsthatirradia-
tion markedly depleted B cells (25, 26), and that transfer of W3/25+ T cells from
naiveorunresponsive hostsdid not restore in alloantibody production, unless large
numbers (106) ofB cells were also given (26). It has been proposed that CD45R+
cells arenaive cells, and that activatedand memory cellscease to express the pheno-
type and express the low molecular weight form ofT200 (47, 48). Ifthis is the case,
the suppressor cell fails to make this switch in T200, and retains the naive T cell
phenotype.
The cells required to produce CD4+ Ts cells were shown not to be recently de-
rived from the thymus, making it likely they are derived from long-lived peripheral
CD4+ cells. Once induced, the CD4+ suppressor cells appeared to have a short life
span, and their sensitivity tocyclophosphamide suggestedtheywere dividing. Their
expression ofanIL-2-R suggested these cellsrequired IL-2 and perhapsothercytokines
to sustain theirsurvival. Preliminary studies have suggested suppressor cells can be
sustained on cultures supplemented with cytokines (Pearce, N. W., K. E. Gurley,
and B. M. Hall, manuscriptin preparation). Afterremoval ofthe graft, the recovery
of the CD4+ populations' capacity to effect rejection was slower the longer the graftHALL ET AL.
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was in place. This finding is consistent with the strengtheningin the degree of un-
responsiveness with time as manifest by the lengtheningin time to rejectionof donor
strain grafts (22, 23, 43).
The precise role of CD8' cells in the mediation of suppression was not directly
resolved by these studies. We have previously shown that CD8+ cells from CSA-
treated hosts lack the capacity to transfer suppression and, in this study, showed
that the normal CD8+ cell population in peripheral lymphoid tissue could be sup-
pressed by CD4', but did not augment induction of suppression. Further, the sen-
sitized CD8+ cell's capacity to affect rejection could also be abrogatedby CD4' cells.
The irradiated hosts, however, had radioresistant CD8' cells in which suppressor
function predominated. This result was in contrast to Roser (35), who found that
transfer of neonatal tolerance is not affected by MRC Ox8 treatment of the irradi-
ated host. In our studies MRC Ox8 treatment of irradiated hosts to deplete them
of CD8+ cells allowed the CD4' cells within the host to effect rejection, thus
abrogating the potential ofirradiation to induce an unresponsive state. In adetailed
examination of this effect (Gurley, K. E. and B. M. Hall, manuscript in prepara-
tion), we have demonstrated that the mediation of rejection in irradiated MRC
Ox8-treated hosts is dependent on CD4' cells regenerated by the thymus, and that
the MRC Ox8-treated hosts remain devoid of CD8' cells for several weeks. Given
these observations, the failure of the CD4' suppressor cells to establish unrespon-
siveness in MRC Ox8-depleted irradiated hostsmay have been dueto an unfavorable
shift in the balance of host lymphoid cells to the effector cascade. We have shown
that the transfer of suppression was dependent upon a suppressor to effector ratio
of 2-4:1, and that with a smaller ratio suppression is not transferred (Hall, B. M.,
unpublished data). In this study, several findings suggested the unresponsive hosts'
CD4' cells were also not depleted of cellswith the potential to effect rejection, par-
ticularly the loss of suppression after 3 d in culture, which is associated with a re-
emergence of CD4+ cells with the capacity to effect rejection. The failure of CD4'
suppressors to prevent rejection in MRC Ox8-treated irradiated hosts suggested
that the radioresistant MRC Ox8' cells were critical for the reestablishment of sup-
pression. The MRC Ox8' cells that facilitate reestablishment of suppression were
not derived from regenerating thymus, however. Whether these MRC Ox8 cells are
Tcells or natural suppressor cells similarto thosedescribed by Strober (49) requires
further studies, as does their role in the reestablishment of suppression; in partic-
ular, whether they acquire specificity.
In nonalloimmune in vivo systems (11, 50) and alloimmune in vitro (16) and in
vivo (14) studies, anetwork ofcells involved in the induction andexpression of toler-
ance has been demonstrated. These studies conclude that CD4' cells act as inducers
and transducers of the suppressor response. The CD4' cells respond to the im-
munizing antigen and mediate their suppressive effect by activating CD8' sup-
pressor effector cells that react to idiotype and are the mediator of suppression by
directly impairing the effector arm of the immune response. In our experiments,
we have not yet elicited what role the CD8' cells play in the mediation of suppres-
sion. The CD8' cells involved in the reinduction of unresponsiveness are not pre-
dominate in mature peripheral T cells, and their role as an effector of suppression
hasnot been established, only a role in facilitating reinduction of unresponsiveness.
Our studies suggest that if MRC Ox8' cells are required for the maintenance of154
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unresponsiveness, they must be highly dependent upon the CD4+ suppressor. One
possibility notexcluded by these experiments is that in mature peripheral lymphoid
cell populations, there is a fine balance between CD8+ cells that are cytotoxic T cell
precursors and those that have suppressor effector potential. As these two popula-
tions can be subdivided inman bythe mAb9.3 (CD28) (51), ifan equivalent reagent
was available in the rat, cytotoxic precursor cells could be depleted so the function
of the CD8+ suppressor subset could be directly assessed.
Whilethesestudieshavefurther characterized the suppressor response thatmediates
unresponsiveness in this strain combination, several important questions remain to
be answered. These include how the transferred CD4+ suppressor and host radio-
resistant CD8+ cells mediate inhibition of CD4+ and CD8+ effector cells. The
specificity ofthe CD4+ suppressor cells' receptor, whether it be idiotypic or antiidio-
typic, also remains to be determined, as does its interaction with the radioresistant
CD8+ cell in the adoptive hosts and the specificity ofthis subpopulation. It is pos-
sible that this cell recognizes donor alloantigen and prevents effective function of
CD4+ and CD8+ cells by release ofnegative regulatory cytokines, orit may directly
interact with these effectors via idiotype. Thesepossibilities are currently under in-
vestigation, as is the best method to propagatethecell in vitro and to detect itspres-
ence by an in vitro assay. The understanding ofthe mechanisms ofthis form ofun-
responsiveness to allografthaspotentialforclinical transplantation, where its induction
may allow minimization of maintenance immunosuppressive drugs.
Summary
The cellular basis ofthe specific unresponsiveness that develops in DA rats treated
with cyclosporine (CSA) for 10 d after grafting a PVG heart was examined using
an adoptive transfer assay. CD4+ cells from rats with long survival grafts specifically
lack the capacity to restore PVG heart graft rejection, and can also inhibit the ca-
pacity ofnaive Tcellsto restorerejection, while inthe firstfewweeks post-transplant,
both CD4+ and CD8+ T cells from CSA-treated hosts have the capacity to effect
PVG graft rejection. In this study, we demonstrated the CD4+ suppressor cells also
had the capacity to inhibit restoration ofrejection by CD4+ cells from CSA-treated
DA rats recently transplanted with PVG hearts, and from rats sensitized to third
party, but not from those specifically sensitized to PVG. They also inhibited the ca-
pacity of both naive CD8+ and sensitized CD8+ cells to effect rejection. These
results showed that the CD4+ suppressor cell was capable ofoverriding the capacity
to effect rejection of the CD4+ cell and activated CD8+ cells that were present in
the CSA-treated host shortly after transplantation. The failure ofnaive CD8+ cells
to augment suppression and the capacity ofCD4+ suppressor cells to transfer un-
responsiveness to irradiated hosts in which regeneration ofCD8+ cells was abolished
by thymectomy suggested that it was the CD4+ cell alone that mediated suppres-
sion. However, the failure ofCD4+ suppressor cells to reinduce unresponsiveness
in irradiated hosts whose CD8+ cells had been depleted by therapy with the mAb
MRC Ox8 showed that a radioresistant CD8+ cell was required to reestablish the
state ofspecific unresponsiveness. The induction ofCD4+ suppressor cells in thy-
mectomized hosts suggested that these cells were derived from long-lived CD4+ lym-
phocytes. However, their sensitivity tocyclophosphamide andtheirloss ofsuppressor
function both after removal ofthe graft and after 3 d in culture demonstrated thatHALL ET AL.
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the suppressor cell itself had a short lifespan. The CD4' suppressor was shown to
be MRC Ox22' (CD45R+), MRC Ox17' (MHC class II), and MRC Ox39'
(CD25, IL-2-R). These studies demonstrated the CD4' suppressive cell identified
in rats with specific unresponsiveness induced by CSA therapy had many features
of the suppressor inducer cell identified in in vitro studies of the alloimmune re-
sponse. The CD4' suppressor cell could account for the downregulation of the
CD4' and CD8' T cells, with the capacity to effect rejection that was present in
the CSA-treated hosts shortly after transplantation, and its action was facilitated
by a radioresistant CD8' cell that did not appear to predominate in mature periph-
eral CD8' T cells.
We thank Austin Spinelli for excellent technical assistance and Mary Peterson for typing of
the manuscript.
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